Welcome to our dedicated page for INSPIRE VETERINARY PARTNERS SEC filings (Ticker: IVP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Inspire Veterinary Partners filings document the public-company record for a Nevada issuer operating in U.S. veterinary and pet health care services. The record includes Form 8-K reports on exchange-listing status, material agreements, amendments to authorized Class A common stock, board changes, and other corporate governance matters.
Registration statements describe securities offerings and issuer classifications, while late-filing notices and Form 15 documentation address periodic reporting status under the Securities Exchange Act. The filings also cover Class A common stock, capital-structure changes, OTCQB trading following Nasdaq delisting, and the company’s formal suspension or termination of Exchange Act reporting duties.
Inspire Veterinary Partners (Nasdaq: IVP) filed an 8-K disclosing two capital-raising arrangements that could supply up to $60 million of new funding but introduce meaningful dilution.
On 28-29 Jul 2025 the company signed a Securities Purchase Agreement for a private placement of up to 7,590 Series B convertible preferred shares (stated value $1,000) plus equal-number warrants. At the first closing investors bought 6,340 preferred shares and 6,340,000 five-year warrants for $5 million. The preferred converts at $1.00 per share (floor $0.1876) and the warrants initially exercise at $1.00, both subject to reset on lower-priced issuances. The stock ranks senior to all other equity, has no voting rights, and carries standard anti-dilution, redemption (125% premium) and change-of-control protections. The company must reserve 250 % of the shares needed for conversion and file a resale registration statement.
Separately, IVP entered a $50 million committed equity line with a single accredited investor. IVP may, at its option, sell up to $5 million of common stock per notice when the market price is ≥$0.75, subject to a 4.99 % ownership cap. Proceeds are earmarked for working capital. Either party can terminate under customary default, delisting or bankruptcy triggers.
- Aggregate potential raise: $60 million
- Immediate cash received: ~$5 million
- Maximum dilution: variable; conversion and warrant floors set at ~$0.19